 |
인쇄하기
취소
|
Ilyang, Merck sign MOU over ilaprazole
Ilyang Pharm and Merck India signed a memorandum of understanding to supply ilaprazole, a new anti-peptic ulcer drug, in its raw material form, to India for the next 10 years on an exclusive basis, it was announced on May 25.
Under the agreement, Merck India will obtain the exclusive right to market ilaprazole in five Asian countries including India.
The pharmaceutical market in India has...
Under the agreement, Merck India will obtain the exclusive right to market ilaprazole in five Asian countries including India.
The pharmaceutical market in India has...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.